White House issues advisories regarding cryptocurrencies being using to purchase illicit drugs

  • The U.S. White House has sent out two advisories to financial institutions, about the drugs being bought with cryptocurrencies.
  • The documents addressed are designed to assist them in detecting suspicious transactions. 

 

The White House has issued two advisories warning that fentanyl and other synthetic opioids are being purchased using major cryptocurrencies.

In terms of the documents, they are addressed to financial institutions in addition to digital payments platforms, which are designed to assist them in detecting suspicious transactions. 

The documents detailed:

The United States “is in the midst of an unparalleled epidemic of addiction and death. An analysis of sensitive financial data indicates that domestic illicit drug manufacturers, dealers, and consumers use online payment platforms or CVC to purchase precursor chemicals or completely synthesized narcotics primarily sourced from China.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.